Patent · US Active

Compounds

US12319680B2 · kind B2 · utility

0Cited by

2References

1Claims

0Family size

Assignee

Step Pharma S.A.S. · FR

Inventors

Andrew Novak · Wentworth Street, GB
Joseph Wrigglesworth · Nottingham, GB

Key dates

Filing date	Oct 10, 2022
Grant date	Jun 3, 2025
Priority date	—
Expiry date	Oct 10, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) and related aspects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.